
Raliago Injection
Marketer
RKM Health Care
Salt Composition
Arteether (NA)
Overview Raliago Injection
Malaria is treated with the injectable antiparasitic drug, Raliago. This medication is administered intravenously by a medical professional only; self-injection is strictly prohibited and reserved for situations where oral medication is infeasible. Raliago is not a preventative measure nor is it effective against severe malaria involving complications in vital organs (brain, lungs, or kidneys). Common side effects include headache, fatigue, lightheadedness, and arthralgia. Injection site reactions such as soreness, inflammation, or erythema may also occur. Persistent or worsening symptoms necessitate immediate medical attention. Post-treatment, weekly blood tests for four weeks may be conducted to confirm parasite eradication.
Primary Ingredients of Raliago Injection
No information provided. Therefore, no rephrased text can be offered.
Uses of Raliago Injection
Plasmodium infection
Major Benefits of Raliago Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Raliago Injection:
- Nausea
- Body ache
- Leg pain
- Chills
- Rigors
- Injection site reactions (pain, swelling, redness)
- Headache
- Dizziness
- Weakness
- Vomiting
- Cough
- Injection site pain
- Abdominal pain
- Diarrhea
How to use Raliago Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Raliago Injection works:
Raliago Injection combats malaria by deploying an antiparasitic mechanism. This involves generating cytotoxic free radicals inside the malaria parasite, leading to its destruction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Raliago Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Raliago Injection use in pregnancy are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Raliago Injection use while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Administering Raliago Injection may induce adverse reactions impacting driving capabilities. Drowsiness and dizziness are potential side effects. Exercise vigilance when operating vehicles or engaging in activities demanding focus.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Raliago Injection's use in patients suffering from renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding Raliago Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Raliago Injection :
Should you forget a scheduled Raliago Injection, contact your physician for guidance.
Facts to Know About Raliago Injection
| Label | Value |
|---|---|
| Chemical Type | Sesquiterpene lactones |
| Developing Habits | No. |
| Treatment Category | Antimalarial Drugs |
| Actions | Artemisinin-based antimalarials |
